Literature DB >> 23686727

Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin.

Sanne H Olesen1, Donna J Ingles, Yan Yang, Ernst Schönbrunn.   

Abstract

Terreic acid is a metabolite with antibiotic properties produced by the fungus Aspergillus terreus, but its cellular target remains unknown. We recently reported that terreic acid inactivates the bacterial cell wall biosynthetic enzyme MurA in vitro by covalent reaction with residue Cys115 in a similar manner as the MurA-specific antibiotic fosfomycin. To address if terreic acid also targets MurA in vivo, we conducted antibacterial studies using selected E. coli strains in parallel with fosfomycin. While overexpression of MurA conferred resistance to fosfomycin, it did not protect cells treated with terreic acid. Furthermore, flow cytometry revealed that the antibiotic action of terreic acid appears to be primarily bacteriostatic, as opposed to the bactericidal action observed for fosfomycin. Combined, the data suggest that MurA is not the molecular target of terreic acid and that the antibiotic activity of terreic acid proceeds through a different mechanism of action. The methodology applied here provides a reliable and convenient tool to rapidly assess the potential of newly discovered in vitro inhibitors to target residue Cys115 of MurA in the cell.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Antibiotics; Drug discovery; Flow cytometry; Natural products; Terreic acid

Mesh:

Substances:

Year:  2013        PMID: 23686727      PMCID: PMC4610358          DOI: 10.1002/jobm.201200617

Source DB:  PubMed          Journal:  J Basic Microbiol        ISSN: 0233-111X            Impact factor:   2.281


  18 in total

Review 1.  Recent advances in the formation of the bacterial peptidoglycan monomer unit.

Authors:  J van Heijenoort
Journal:  Nat Prod Rep       Date:  2001-10       Impact factor: 13.423

Review 2.  Structure and function of the Mur enzymes: development of novel inhibitors.

Authors:  Ahmed El Zoeiby; François Sanschagrin; Roger C Levesque
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

3.  The UDP-N-acetylglucosamine 1-carboxyvinyl-transferase of Enterobacter cloacae. Molecular cloning, sequencing of the gene and overexpression of the enzyme.

Authors:  C Wanke; R Falchetto; N Amrhein
Journal:  FEBS Lett       Date:  1992-04-27       Impact factor: 4.124

4.  Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis.

Authors:  Koen A L De Smet; Karen E Kempsell; Alex Gallagher; Ken Duncan; Douglas B Young
Journal:  Microbiology (Reading)       Date:  1999-11       Impact factor: 2.777

5.  Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin.

Authors:  T Skarzynski; A Mistry; A Wonacott; S E Hutchinson; V A Kelly; K Duncan
Journal:  Structure       Date:  1996-12-15       Impact factor: 5.006

6.  Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.

Authors:  D H Kim; W J Lees; K E Kempsell; W S Lane; K Duncan; C T Walsh
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

7.  Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.

Authors:  Gerardo D Francisco; Zhong Li; J Donald Albright; Nancy H Eudy; Alan H Katz; Peter J Petersen; Pornpen Labthavikul; Guy Singh; Youjun Yang; Beth A Rasmussen; Yang-I Lin; Tarek S Mansour
Journal:  Bioorg Med Chem Lett       Date:  2004-01-05       Impact factor: 2.823

8.  Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme.

Authors:  E Z Baum; D A Montenegro; L Licata; I Turchi; G C Webb; B D Foleno; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli.

Authors:  E D Brown; E I Vivas; C T Walsh; R Kolter
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  4 in total

1.  Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus.

Authors:  Hai Liang; Guangfeng Zhou; Yunhui Ge; Elizabeth A D'Ambrosio; Tess M Eidem; Catlyn Blanchard; Cindy Shehatou; Vijay K Chatare; Paul M Dunman; Ann M Valentine; Vincent A Voelz; Catherine L Grimes; Rodrigo B Andrade
Journal:  Bioorg Med Chem       Date:  2018-05-24       Impact factor: 3.641

2.  Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.

Authors:  Laura B Ferguson; Angela R Ozburn; Igor Ponomarev; Pamela Metten; Matthew Reilly; John C Crabbe; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2017-12-18       Impact factor: 7.853

3.  Soybean-associated endophytic fungi as potential source for anti-COVID-19 metabolites supported by docking analysis.

Authors:  S S El-Hawary; R Mohammed; H S Bahr; E Z Attia; M H El-Katatny; N Abelyan; M M Al-Sanea; A S Moawad; U R Abdelmohsen
Journal:  J Appl Microbiol       Date:  2021-03-09       Impact factor: 4.059

Review 4.  Advances in UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Covalent Inhibition.

Authors:  Maycon Vinicius Damasceno de Oliveira; Renan Machado Furtado; Kauê S da Costa; Serhii Vakal; Anderson H Lima
Journal:  Front Mol Biosci       Date:  2022-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.